Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lasko, Maxwell J
29  Ergebnisse:
Personensuche X
?
1

Trimethoprim/sulfamethoxazole pharmacodynamics against Sten..:

Lasko, Maxwell J ; Tabor-Rennie, Jennifer L ; Nicolau, David P.
Journal of Antimicrobial Chemotherapy.  77 (2022)  11 - p. 3187-3193 , 2022
Link: https://doi.org/10.1093/..
 
?
2

Pharmacodynamics of Ceftibuten: An Assessment of an Oral Ce..:

Lasko, Maxwell J. ; Asempa, Tomefa E. ; Nicolau, David P.
Antibiotics.  10 (2021)  2 - p. 201 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Clinical exposure–response relationship of cefepime/tanibor..:

Lasko, Maxwell J. ; Nicolau, David P. ; Asempa, Tomefa E.
Journal of Antimicrobial Chemotherapy.  77 (2021)  2 - p. 443-447 , 2021
Link: https://doi.org/10.1093/..
 
?
4

Contemporary analysis of ETEST for antibiotic susceptibilit..:

Lasko, Maxwell J. ; Huse, Holly K. ; Nicolau, David P..
Annals of Clinical Microbiology and Antimicrobials.  20 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
5

Evaluation of high-concentration EDTA-modified carbapenemas..:

Lasko, Maxwell J. ; Cuba, Gabriel T. ; Kiffer, Carlos R. V..
Archives of Microbiology.  204 (2021)  1 - p. , 2021
Link: https://doi.org/10.1007/..
 
?
6

Comparative in vivo activity of human-simulated plasma and ..:

Lasko, Maxwell J. ; Abdelraouf, Kamilia ; Nicolau, David P.
Journal of Antimicrobial Chemotherapy.  76 (2021)  9 - p. 2310-2316 , 2021
Link: https://doi.org/10.1093/..
 
?
7

1245. In Vivo Efficacy of WCK 4282 (High Dose Cefepime [FEP..:

Lasko, Maxwell J ; Abdelraouf, Kamilia ; Nicolau, David P
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S641-S641 , 2020
Link: https://doi.org/10.1093/..
 
?
8

1317. Pharmacokinetics (PK) of Ampicillin-Sulbactam (SAM) d..:

Lasko, Maxwell J ; Serrano, Oscar ; Nicolau, David P.
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S670-S670 , 2020
Link: https://doi.org/10.1093/..
 
?
9

13. Evaluation of Etest for Antibiotic Susceptibility and M..:

Lasko, Maxwell J ; Huse, Holly ; Kuti, Joseph L.
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S7-S8 , 2020
Link: https://doi.org/10.1093/..
 
?
10

EDTA-modified carbapenem inactivation method (eCIM) for det..:

Lasko, Maxwell J. ; Gill, Christian M. ; Asempa, Tomefa E..
BMC Microbiology.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
11

1308. Ex vivo Impact of Autologous Blood Transfusion (ABT) ..:

Lasko, Maxwell J ; Conelius, Allison ; Serrano, Oscar..
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S667-S667 , 2020
Link: https://doi.org/10.1093/..
 
?
12

1602. Comparative Activity of Ceftolozane-Tazobactam (C/T) ..:

Lasko, Maxwell J ; Nicolau, David P ; Kuti, Joseph L
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S797-S797 , 2020
Link: https://doi.org/10.1093/..
 
?
13

Carbapenem-Resistant Enterobacterales: Considerations for T..:

Lasko, Maxwell J. ; Nicolau, David P.
Current Infectious Disease Reports.  22 (2020)  3 - p. , 2020
Link: https://doi.org/10.1007/..
 
?
14

In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole..:

Lasko, Maxwell J ; Gethers, Matthew L ; Tabor-Rennie, Jennifer L..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923228/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Pharmacodynamics of Ceftibuten: An Assessment of an Oral Ce..:

Lasko, Maxwell J ; Asempa, Tomefa E ; Nicolau, David P
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922365/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15